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Pathophysiological Processes

Introduction:
Disseminated
Intravascular
Coagulation
•

•

•
•

Disseminated Intravascular
Coagulation (DIC) is a deadly
thrombohemorrhagic disorder
brought on by a secondary
illness (Schub & Balderrama,
2018).
In all hospitalized patients
admitted to the intensive care
unit (ICU), DIC accounts for
roughly 19% (Boral et al., 2016).
The mortality rate for the most
severe cases of DIC can be up to
78% (Boral et al., 2016).
Determining the onset and
duration of DIC can be tricky and
often prolonged.

Why Disseminated
Intravascular
Coagulation?
•

•

•

•

•

DIC was first clinically observed in
the 19 century, but only over the
past few decades has a
comprehension of its
pathogenesis been achieved
(Papageorgiou et al., 2018).
DIC can emerge from commonly
seen diagnoses in the health care
setting.
Sepsis, trauma, malignancy,
complications from obstetrics,
vascular deformities,
immunological reactions, and
post-arrest recovery are most
notably linked as precipitating
conditions leading to DIC (Levi &
Scully, 2018).
DIC is only scrutinized by health
professionals when there is a
presentation of substantial,
uncontrolled bleeding, even
though organ dysfunction from
microvascular ischemia gives rise
to DIC too (Thachil, 2016) .
As anesthesia professionals and
nurses, DIC must be taken
seriously, identified early and be
able to intervene promptly.

Underlying
Pathophysiology

Signs & Symptoms
•

•

•
•

•

•
•

Distinct bleeding and oozing is
often times the first discovered
sign of DIC (Schub & Balderrama,
2018).
Unforeseen bruising, bleeding
from multiple areas (e.g., nose,
gums, vagina, wounds and
venipuncture sites) to name a few
(Schub & Balderrama, 2018).
Severe pain in the back, chest and
chest (Schub & Balderrama,
2018).
Tachycardia, hypotension,
shortness of breath, and altered
mental status have been noted
(Schub & Balderrama, 2018).
Patients can have abnormal lab
values and be asymptomatic with
low grade DIC (Schub &
Balderrama, 2018).
There is not one definitive
laboratory (lab) test for DIC
(Smith, 2021).
Diagnostic lab test such as
prolonged prothrombin time (PT),
and activated partial
thromboplastin time (aPTT), low
fibrinogen, elevated D-dimer, and
thrombocytopenia aid in DIC
diagnosis (Smith, 2021).

•

•

•

•

DIC is a condition where clotting
activation overcomes the body's
own natural anticoagulants to
produce excessive thrombus
which results in depletion of
coagulation factors and platelets
leading to excessive bleeding
(Levi, 2018).
DIC can be differentiated as either
be Acute or Chronic (Boral et al.,
2016).
Acute DIC is a consumption
coagulopathic state caused by
creating a surplus of thrombin
that out number’s normal
anticoagulants as a result of
elevated tissue factor in the
intravascular space (e.g., infection,
transfusion reactions,
trauma/crush injury, burns,
transplant rejections) to list a few
(Boral et al., 2016).
Chronic DIC precipitates from
prolonged exposure to smaller
amounts of thrombin (e.g.,
malignancies, metastasis,
intrauterine fetal death,
hematomas, aneurysms and
vasculitis) to name a few (Boral et
al., 2016).

Significance of Physiology
To comprehend DIC, one must understand normal physiological hemostasis.
Normal physiological hemostasis is achieved through formation of a platelet plug
from platelet adhesion and aggregation, then followed by the activation of the
coagulation cascade to form a fibrin clot. A sequence of enzymatic steps allow for
thrombin to form. Next, thrombin is converted to soluble fibrinogen and then to
an insoluble fibrin clot that forms a mesh including the previously noted platelet
plug (Boral et al., 2016).
The normal physiological coagulation cascade is made up of two pathways,
intrinsic and extrinsic.. The intrinsic pathway is comprised in order of factor XII,
XI, IX, and VIII. The extrinsic pathway is initiated by Tissue Factor (TF) or factor
III and then to factor VII. Both pathways lead to the final common pathway
activating factor X, V, II, I (fibrin) (Boral et al., 2016).
International Society on Thrombosis and Haemostasis (ISTH) is one of several
scoring systems used to aid in DIC diagnosis (Smith, 2021).
Worldwide, ISTH has been adopted as the gold standard for DIC diagnosis (Iba &
Levy, 2020).
Diagnostic algorithm for acute DIC developed by the Scientific Subcommittee on
DIC of the ISTH uses common coagulation tests and the patient needs to have a
disease associated with DIC. The algorithm has a 93% sensitivity and 97% specific
for acute DIC (Boral et al., 2016).

•

•

•
•
•

Implications for
Nursing Care
•

•

•

•

~~
•
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Conclusions

For nurses and anesthesia
professionals, it is imperative to
perform a thorough history and
physical assessment for each
patient (Smith, 2021).
Nurses and anesthesia
professionals should display highlevel clinical expertise and
understanding to be able to quickly
identify DIC as well as interpreting
vital lab results (Smith, 2021).
Being proactive and advocating
with the multidisciplinary team for
timely and appropriate orders and
interventions (Smith, 2021).
Providing exceptional patient and
family education will allow for
better understanding of current
situation which will allow them to
be better prepared for the
treatment (Smith, 2021).
Effective on-going communication
between treatment team, patient,
and their families is something that
cannot be taken lightly.

•

•

•

•

•

DIC is identified as a lifethreatening medical condition that
includes extensive activation of
coagulation factors, leading to
thrombotic events and organ
dysfunction as well as simultaneous
depletion of those coagulation
factors contributing to massive,
uncontrolled hemorrhaging (Levi &
Scully, 2018).
DIC is always a secondary
complication from an underlying
medical condition (Levi & Scully,
2018).
The occurrence of DIC is
uncommon in the average
hospitalized patient but accounts
for around 9%-19% of ICU
admitted patients which carries a
mortality rate between 45%-78%
(Boral et al., 2016).
Prompt identification of DIC is vital
to applying life-saving interventions
(Smith, 2021).
Nursing should be knowledgeable
and aware in the correct
interventions based on all clinical
indicators.
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Treatment
•

Cancer

Trauma
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•
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Hematologic malignancy
(Iba et al., 2019, Figure 1)

The first initial step in treating DIC is to remove the underlying causative source
(e.g., trauma, infection, malignancy, reactions, etc.) (Papageorgiou et al., 2018).
Next, treatment strategy and options should closely be reflective of the most recent
set of lab values such as PT/INR, PTT, platelet count, fibrinogen, and D-dimer
(Papageorgiou et al., 2018).
The uses of new global coagulation assays like whole blood
thromboelastography/thromboelastography (TEG) drives optimal treatment
(Papageorgiou et al., 2018).
Administer blood components: fresh frozen plasma (FFP) for INR >1.5, platelets for
platelet count <50,000/ µL, cryoprecipitate (cryo) for fibrinogen level <100 mg/dL
and red blood cells (RBC) for hematocrit <21% (Boral et al., 2016).
For patients with continued bleeding after blood component administration with
evidence of hyperfibrinolysis syndrome, administer an antifibrinolytic like
tranexamic acid (TXA). Heparin therapy may also be considered in
hypercoagulability states with deep vein thrombosis (DVT) or pulmonary embolism
(PE) (Boral et al., 2016).
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